Print Page  Close Window

SEC Filings

8-K
EIGER BIOPHARMACEUTICALS, INC. filed this Form 8-K on 01/07/2019
Entire Document
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Eiger BioPharmaceuticals, Inc.
Dated: January 7, 2019    
    By:  

/s/ Sriram Ryali

      Sriram Ryali
      Chief Financial Officer